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httpResults of the Anaconda endovascular graft in
abdominal aortic aneurysm with a severe angulated
infrarenal neck
Steffan G. J. Rödel, MD, MSc,a,d Clark J. Zeebregts, MD, PhD,b Ad B. Huisman, MD, PhD,c and
Robert H. Geelkerken, MD, PhD,d on behalf of the Multicenter Angulated Neck Study with the Anaconda
study participants,* Groningen and Enschede, The Netherlands
Objective: Proximal neck anatomy of an abdominal aortic aneurysm (AAA), especially a severe angulated neck of more
than 60 degrees, predicts adverse outcome in endovascular aneurysm repair. In the present study, we evaluate the
feasibility of the use of the Anaconda endovascular graft (Vascutec, Terumo, Inchinnan, Scotland) for treating infrarenal
AAA with a severe angulated neck (>60 degrees) and report the midterm outcomes.
Methods: In total, nine Dutch hospitals participated in this prospective cohort study. From December 2005 to January
2011, a total of 36 AAA patients, 30 men and six women, were included. Mean and median follow-up were both
40 months.
Results:Mean infrarenal neck angulation was 82 degrees. Successful deployment was reached in 34 of 36 patients. Primary
technical success was achieved in 30 of 36 patients (83%). There was no aneurysm-related death. Four-year primary
clinical success was 69%. In the ﬁrst year, eight clinical failures were reported including four leg occlusions which could be
solved using standard procedures. After the ﬁrst year, three patients with additional failures occurred; two of them were
leg occlusions. Four patients needed conversion to open AAA exclusion. In six of 36 patients, one or more reinterventions
were necessary. Three of them were performed for occlusion of one Anaconda leg and two were for occlusion of the body.
Conclusions: The use of the Anaconda endovascular graft in AAA with a severe angulated infrarenal neck is feasible but has
its side effects. Most clinical failures occur in the ﬁrst year. Thereafter, few problems occur, and midterm results are
acceptable. Summarizing the present experiences, we conclude that open AAA repair is still a preferable option in patients
with challenging aortic neck anatomy and ﬁt for open surgery. (J Vasc Surg 2014;59:1495-501.)Since its introduction, endovascular aneurysm repair
(EVAR) has gained widespread adoption as a routine treat-
ment alternative for patients with abdominal aortic aneu-
rysm (AAA). However, it has become clear that the
failure of EVAR depends both on features of AAA anatomy
and endovascular graft characteristics. The proximal AAA
neck anatomy, especially a severe angulated neck of more
than 60 degrees, predicts adverse outcome in EVAR.1-5
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://dx.doi.org/10.1016/j.jvs.2013.12.034Learning from the experience with ﬁrst-generation
endovascular grafts, and because of technological ad-
vances, the latest generations of commercially available
endovascular grafts have been clearly improved. Modiﬁca-
tion and redesigning of the endovascular graft with spe-
ciﬁc attention to ﬂexibility, proximal ﬁt, and sealing
intended to decrease the chance of type I endoleak and
endovascular graft migration.7-9 As a consequence, indi-
cations outside instructions for use (IFU) were sought
in patients with hostile neck anatomy unﬁt for open
repair.10-16
The Anaconda endovascular graft (Vascutec, Terumo,
Inchinnan, Scotland) was designed with the intention of
addressing some of the failure modes observed in the
1990s. Hypothetically, because of the zero body columnar
strength design and the high ﬂexibility of the system during
placement, it should be feasible to utilize the Anaconda in
AAAs with severe infrarenal angulations.17
In the present study we evaluated the feasibility and
midterm outcomes of the Anaconda endovascular graft
for treating infrarenal AAA with a severe angulated neck.
METHODS
In total, nine Dutch hospitals participated in this pro-
spective cohort study. From December 2005 to January
2011, a total of 36 AAA patients, 30 men and six women,
were included. Mean and median follow-up were both
40 months (range, 0-69 months).1495
Table I. Inclusion and exclusion criteria
Inclusion criteria
Patient willing and available to comply with follow-up
requirements
Patient can comply with instructions and gives informed consent
Life expectancy >2 years
AAA >50 mm in diameter
Symptomatic small AAA
Infrarenal proximal neck diameter 18-31.5 mm
Infrarenal proximal neck length $15 mm
Infrarenal aortic angulation >60
Distal iliac ﬁxation site diameter <16 mm and >30 mm in
length
Access vessels >7.5 mm in diameter
Exclusion criteria
Ruptured or symptomatic AAA
Juxtarenal or suprarenal extension of aneurysm
Low operative risk for open repair
Presence of serious concomitant medical disease or infection
Known allergy to contrast medium, nitinol, or polyester
Inability to preserve at least one hypogastric artery
Connective tissue disease
ASA grade IV or V
Need for surgical reconstruction of other visceral arteries
Presence of >50% continuous calciﬁcation of proximal neck
Presence of >50% thrombus in proximal neck
AAA, Abdominal aortic aneurysm;ASA, American Society of Anesthesiologists.
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neck angulation of 60 degrees or more were eligible for in-
clusion in the Multicenter Angulated Neck Study with the
Anaconda endovascular graft (MANSA). Table I presents
an enumerative description of all the inclusion and exclu-
sion criteria for the MANSA study. The study protocol was
approved by the institutional review board. Aneurysm
anatomy was deﬁned through the use of Eurostar criteria.18
Each patient underwent a detailed preoperative
screening to evaluate suitability for inclusion in the study.
The information collected consisted of a general health
analysis including the Society of Vascular Surgery/
International Society of Cardiovascular Surgery (SVS-
ISCVS) risk scores for diabetes mellitus, smoking, hyper-
tension, hyperlipidemia, and cardiac, carotid, renal, and
pulmonary disease, as well as American Society of Anesthe-
siologists (ASA) classiﬁcation and ankle-brachial index.
Preoperative AAA assessment included detailed spiral
computed tomography (CT) scanning and angiography
as described in a previous study with the Anaconda endo-
vascular graft (ANA-004 study).19
Study hypothesis and deﬁnitions. The primary
objectives of the MANSA study were to examine the tech-
nical and clinical success of the Anaconda endovascular
graft for the treatment of AAA with a severe angulated
infrarenal neck. The outcome parameters were outlined
in detail in ANA-004 and were in line with the previous
published guidelines for reports concerning EVAR by
Chaikof et al.20
Clinical success is reported as short-term clinical suc-
cess (30 days) and midterm clinical success (up to 4 years
of follow-up).
Device description. The Anaconda AAA Stent Graft
System is a three-piece endovascular graft. The stents
were made of multiple-element nitinol stents internally
covered with woven polyester graft material. The top of the
endovascular graft consists of a dual-ring stent design,
resembling the Anaconda snake. The proximal ring stent is
anchored in an infrarenal position by four pairs of nitinol
hooks, which prevent device migration. The body is
unstented, resulting in zero column strength and adapt-
ability in angulated proximal vascular anatomy. The iliac
legs are fully supported with independent nitinol ring
stents, which prevent kinking and provide ﬂexibility with
ﬁxation in tortuous distal iliac and femoral anatomy. The
delivery device of the main body has an outer diameter of
20.4F or 22.5F (6.8-7.5 mm), depending of the stent graft
neck diameter used. The delivery system for the iliac legs
has an outer diameter of 18.3F (6.1 mm). The Anaconda
AAA Stent Graft System can be fully repositioned by use of
the control collar of the delivery system handle. The can-
nulation of the contralateral gate of the body is facilitated
with a magnet system that uses a preloaded magnet wire to
assist in the cannulation and deployment of the contralat-
eral iliac leg.
Operative procedure. All surgery was performed elec-
tively with a radiolucent table under ﬂuoroscopic guidance.
The endovascular graft was selected according to AAAanatomy, with special attention for at least 20%-30% over-
sizing of the prosthetic body in relation to the infrarenal
neck diameter. The procedure was carried out under local
(n ¼ 9), epidural (n ¼ 26), or general (n ¼ 1) anesthesia,
by means of standard surgical exposure of femoral arteries
with the use of surgical cut-down and arteriotomy. For
anticoagulation during the procedure, intravenous heparin
(100 IU/kg body weight) was given in accordance with
standard endovascular procedures. A second heparin dose
was given when the EVAR procedure exceeded 2 hours of
operative time.
First, on both sides, a stiff .035 wire (Backup Meier;
Boston Scientiﬁc, Natick, Mass) was introduced up to the
aortic arch. When iliac and aortic angulations could not
be straightened with the use of stiff wires, one or two endo-
vascular sheaths (Cook Medical Europe Ltd, Limerick,
Ireland) were used. The zero columnar strength of the
body caused by the unstented segment is problematic in
the severely angulated distal part of the infrarenal aortic
neck. To prevent infolding of the body, the starting point
of the release of the iliac legs in the body was therefore
close to the proximal body stent rings at a distance above
the level of the aortic rim and angulation. In this way,
the body is supported in this crucial place and kinking or
infolding was diminished.
If applicable, the legs were extended to the common
iliac bifurcation. All necessary operative details, overall
outcome of the procedure, as well as any adverse event dur-
ing operation were recorded.
Follow-up protocol. The study included postopera-
tive follow-up at discharge and at 3, 6, 12, 18, and
24 months and yearly thereafter to assess clinical success or
failure. Each patient underwent postoperative CT scanning
Table II. Patient characteristics
Demographic Number of patients
Mean age (range), years 74 (61-84)
Sex
Male 30
Female 6
ASA grade
I 1
II 29
III 6
Unknown 0
Diabetics
Normal 19
Only diet-controlled 6
Diet þ drugs 11
Smoking
Not in past 10 years 22
Ex-smoker 6
Smoker 8
Hypertension
None 18
1-2 Drugs 14
3þ/Uncontrolled 4
Hyperlipidemia
Normal 19
Mild 6
Diet þ drugs 11
Cardiac disease
Normal 18
Asymptomatic, MI 7
Angina, etc 11
Carotid disease
No disease 29
Asymptomatic 1
Transient stroke 6
Completed stroke 0
Renal disease
Normal 32
Increased creatinine 4
Pulmonary disease
Normal 28
Mild 3
Moderate 4
Severe 1
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesi-
ologists; MI, myocardial infarction.
Table III. Eurostar type of abdominal aortic aneurysm
(AAA) morphology
Anatomical criteria No. Range (median)
Total number of patients 36 -
Eurostar type of AAA
A 9 -
B 23 -
C 1 -
D 3 -
E 0 -
Etiology
Atherosclerosis 36 -
Other 0 -
Shape aneurysm
Fusiform 35 -
Sacculair 1 -
Other 0 -
Diameter infrarenal neck
D2a, mm 23 16-31
D2b, mm 23 17-29
D2c, mm 23 17-31
Neck shape (Balm)4
¼ jj 24 -
¼/ \ 4 -
¼ \ / 3 -
¼ <> 2 -
¼ >< 3 -
Length, mm 28 10-45 (30)
Circumferential thrombus
% D2 a-b-c Max 80-20-20
Circumferential calciﬁcation
% D2 a-b-c Max 10-20-30
Angulation aortic neck, AAA, degrees 82 60-133 (80)
Aneurysm diameter
D3, mm 71 45-100 (68)
Diameter right common iliac artery
Proximal, mm 14
Mid, mm 15 9-19
Distal, mm 14
Angulation, degrees 51 0-150
Diameter left common iliac artery
Proximal, mm 15
Mid, mm 14 9-63
Distal, mm 15
Angulation, degrees 41 0-180
Diameter right external iliac artery, mm 10 8-14
Angulation, degrees 48 0-150
Diameter left external iliac artery, mm 10 9-14
Angulation, degrees 48 0-180
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abdominal radiography thereafter.
Recorded follow-up data included overall survival;
death as a result of aneurysm-related treatment; conversion
to open repair; endoleak; reintervention; aneurysm expan-
sion or rupture; renal artery occlusion; and endovascular
graft infection, thrombosis, migration, dilatation, or failure
of integrity of exoskeleton structure.
Statistical analysis. Only descriptive statistics were
performed, and mean, median, or range are reported
when appropriate.
RESULTS
Patient and anatomical characteristics
Patient characteristics are summarized in Table II and
anatomical characteristics in Table III. Mean infrarenalneck angulation in this cohort of AAA patients was 82 de-
grees (range, 60-133 degrees). Mean aneurysm diameter
was 71 mm, ranging from 45 mm (symptomatic small
AAA) to 100 mm. In Table IV, the outcome parameters
up to 4 years of follow-up are listed.
Technical success
Primary technical success was achieved in 30 of 36 pa-
tients (83%). There were two serious adverse events
(SAEs) during the initial EVAR procedure. In one patient,
an improper released Anaconda body below the aortic
neck angulation could not be repositioned upstream
Table IV. Clinical success
30 days 1st year 2nd year 3th year 4th year Totalb
Number in cohort 36 36 35 31 27 36
Lost to follow-up 2 6% (2/36)
All-cause mortality 0% (0/36) 3% (1/36) 6% (2/35) 0% (0/31) 19% (5/27) 22% (8/36)
Aneurysm-related death 0% (0/36) 0% (0/36) 0% (0/35) 0% (0/31) 0% (0/27) 0%
Primary clinical success 89% (32/36) 78% (28/36) 74% (26/35) 71% (22/31) 77% (21/27) 69% (25/36)
Primary assisted and secondary
clinical success
94% (34/36) 83% (30/36) 80% (28/35) 77% (24/31) 81% (23/27) 75% (27/36)
Clinical failurea 11% (4/36) 11% (4/36) 3% (1/35) 3% (1/31) 4% (1/27) 31% (11/36)
SAEs 11% (4/36) 8% (3/36) 3% (1/35) 3% (1/31) 4% (1/27) 27% (10/36)
Conversion 2 1 1 11% (4/36)
Limb occlusion 1 2 1 3 0 14% (5/36)
Freedom from re-intervention 89% (32/36) 83% (29/35) 80% (25/31) 83% (30/36)
Freedom from migrationb 100% (36/36) 100% (35/35) 97% (30/31) 97% (26/27) 94% (34/36)
SAEs, Serious adverse events.
aExcluded: Death not aneurysm-related. Included primary assisted and secondary clinical success (two patients).
bIntention to treat.
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conversion to open repair was necessary.
In another patient, deployment of the contralateral
Anaconda leg failed. In the already-deployed Anaconda
main body, an aortouni-iliac endovascular graft (Talent;
Medtronic, Minneapolis, Minn) with additional femoral-
femoral crossover bypass was placed. This patient died of
metastatic colonic malignancy in the fourth year of
follow-up and developed in his last week a possible para-
neoplastic occlusion of the Anaconda stent just distal
from the renal arteries, which may have contributed to
the death of this patient.
There were four type I endoleaks at the end of the im-
plantation. Because of the adaptability of the two saddle-
shaped proximal stent rings, conservative treatment was
initiated. Three of these four type I endoleaks resolved,
with no signs of endoleak on the postoperative CT scan
at discharge. The fourth patient with type I endoleak was
initially treated with a proximal aortic extension cuff
(Talent), and selective embolization of the type I endoleak.
CT scanning on the ﬁfth postoperative day demonstrated
persisting type I endoleak and occlusion of the left renal ar-
tery. This artery was unintentionally partially covered by
the aortic extension cuff. A partial conversion suturing
the Anaconda body onto the native aorta was done. In
the third-year follow-up, a type II endoleak was discovered
and treated with coiling because of slight growth of the
AAA. Unfortunately, after 49 months of follow-up, a con-
tained AAA rupture caused by proximal anastomotic suture
dislodging occurred. Resuturing of the proximal Anaconda
body was performed successfully.
Thirty-day clinical success
During the ﬁrst 30 days, the all-cause mortality rate
was 0% (Table IV). Mean and median hospital stays
were 8 and 6 days (range, 3-30 days), respectively. A total
of 13 patients were hospitalized between 3 and 5 days.
One patient was re-admitted after 30 days, mainly
because of respiratory problems. There were 11 type IIendoleaks at discharge CT. The 30-day primary clinical
success was 89% and assisted primary and secondary clin-
ical success 94%. There were four 30-day clinical failures
and SAEs (11%).
One-year clinical success
The ﬁrst-year primary clinical success rate was 28/36
(78%). The primary assisted and secondary clinical success
rates were 30/36 (83%). There were four additional clinical
failures after 30 days, including two occlusions of the main
body and two leg occlusions. In three of these four pa-
tients, additional interventions were necessary (femoral-
femoral crossover bypass, recanalization of the stent
body, conversion to an open bifurcated prosthesis). The
fourth patient remained asymptomatic, and a conservative
policy was followed. One patient died during the ﬁrst
year because of advanced age with general exhaustion.
Midterm clinical success
After 4 years, two patients were lost to follow-up. At
4 years, the aneurysm-related mortality rate was zero. All-
cause mortality rate was 8/36 (22 %). The 4-year primary
clinical success rate was 25/36 (69 %). The primary assisted
and secondary clinical success rates were both 27/36 pa-
tients (75%). Eight of 11 clinical failures and seven of 10
SAEs occurred in the ﬁrst postoperative year.
Other clinical failures, reinterventions, and SAEs
Occlusion of the Anaconda body. One patient
perceived a complete occlusion of the Anaconda body
1 week after a herniated nucleus pulposus operation. We
speculated that during the operation in which the patient
was resting on his belly and positioned with 90 degree
hip ﬂexion, the Anaconda endovascular graft was inadver-
tently compressed. Complete conversion and implantation
of a conventional Dacron aortobi-iliac prosthesis was
performed.
In one patient, an occlusion of the Anaconda body
occurred 11 months after the implantation. Percutaneous
Fig. The Anaconda One-Lok endovascular graft (Vascutec, Ter-
umo, Inchinnan, Scotland), introduced in 2011, is a modiﬁcation
of the Anaconda used in this study. Compared with the Anaconda
used in this study, the One-Lok has two additional midrings in the
region of the body and a universal diameter limb docking zone.
Table V. Suitability for endovascular aneurysm repair
(EVAR) according to instructions for use (IFU)
Type Infrarenal angulation and neck length
Anacondaa #60 and $15 mm
Zenithb <60and $15 mm with suprarenal
angulation of <45
Excluderc #60 and $15 mm
Talentd #60 and $10 mm
Endurantd <60and $15 mm with suprarenal
angulation of #45
#75 and $15 mm with suprarenal
angulation of #60
Aorﬁxe #90 and $15 mm
AFXf #60 and $15 mm
Powerlinkf #60 and $15 mm
aVascutec, Terumo, Inchinnan, Scotland.
bCook Medical Europe Ltd, Limerick, Ireland.
cW. L. Gore and Associates, Newark, NJ.
dMedtronic, Minneapolis, Minn.
eLombard Medical Technologies, Didcot, UK.
fEndologix, Irvine, Calif.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 6 Rödel et al 1499recanalization of the body was established by insertion of
two self-expandable stents at the level of the ﬂow splitter.
Four months later, this patient presented with a contained
AAA rupture. A complete conversionwith insertion of a con-
ventional Dacron aortobi-iliac prostheses was carried out.
Occlusion of an Anaconda leg. One patient had a
symptomatic occlusion of the left Anaconda leg 1 month
after operation. Thrombectomy was performed, but re-
occlusion occurred within 3 months. A femoral-femoral
crossover bypass resolved the clinical symptoms, and a
type II endoleak was coiled. One patient had a symptom-
atic occlusion of the left Anaconda leg. A femoral-femoral
crossover bypass was done. One patient had a symptomatic
occlusion of the right leg. In this patient, thrombectomy
and percutaneous transluminal angioplasty of the common
and external iliac artery were successful.
One patient had an asymptomatic occlusion of the left
Anaconda leg that was treated conservatively. Finally,
another patient had an occlusion of the left leg, a stenotic
right leg, and migration of the stent with rotation but was
asymptomatic and treated conservatively.
Migration. One patient had migration of the
Anaconda body as the result of neck dilation, producing
a type I endoleak. Conservative treatment but also revision
with the use of a triple fenestrated Anaconda extension are
considered.
DISCUSSION
The present study, with a mean follow-up of 40months,
demonstrated that EVAR in patients with hostile neck anat-
omy outside Anaconda IFU criteria provided acceptable
primary and secondary results without aneurysm-related
mortality. The features of the second-generation Anaconda
endovascular graft, such as repositionability of the twoproximal stent rings during deployment and the unsup-
ported and therefore more ﬂexible main body, appear to
expand the applicability of EVAR in AAA beyond 60 de-
grees of neck angulation.
The number of leg occlusions was ﬁve out of 36 (14%)
in total, and three of them occurred in the ﬁrst year after
implantation. As mentioned in the ANA-004 study, leg
occlusion in the Anaconda endovascular graft was mainly
observed in patients with small body diameter (<25 mm)
and relatively large-diameter legs. The combination with
steep neck angulations exacerbated the possibility of leg oc-
clusions and could have propagated ultimately to body oc-
clusion. On the basis of these observations, the sizing and
reference chart of the Anaconda endovascular graft con-
cerning the body leg combination was adjusted. A second
modiﬁcation to further reduce leg occlusion was the intro-
duction of the Anaconda One-Lok system in 2011 (Fig);
every leg ﬁts in every body, abolishing body and leg
mismatch. The One-Lok system was introduced after
closure of the current study, and clinical results of the
One-Lok system in AAA with severe angulated necks are
not available yet.
Carpenter et al21 mentioned in their study several
causes of leg occlusion. Direct extrinsic compression of
the limb in the iliac trajectory caused by vessel stenosis or
tortuosity could provide a friction point for the introduc-
tion of twists. As a result of this, occlusion can occur.
Also, a severe calciﬁed and relatively narrow aortic bifurca-
tion can become a fulcrum for the graft to bend or twist.
Extrinsic limb compression caused by luminal thrombus
within the aneurysm can compromise the limb outﬂow.
With only one case of a migrated Anaconda body
caused by neck dilation, the migration rate appears to be
low. The mechanical characteristics of the Anaconda
saddle-shaped proximal ﬁxation and sealing rings including
four hooks were clearly demonstrated in an experimental
JOURNAL OF VASCULAR SURGERY
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proximal neck seal lengths of 15 and 10 mm in three
different types of stents.22 The Anaconda endovascular
graft produced the second-highest DF in the neck and
the highest DF in the distal ﬁxation zone; distally, the
“ﬁsh-mouth” conﬁguration also increased the friction of
the vessel wall.23 The high DF migration of an appropri-
ately oversized Anaconda endovascular graft is rare, even
in very challenging environments such as highly angulated
necks. Latest-generation endovascular graft IFU include a
neck angle varying between 60 degrees or less, with a min-
imum of 10-15 mm neck length, 75 degrees or less with
the use of the Endurant, or 90 degrees or less with the
use of the Aorﬁx, according to IFU. The IFU of the two
endovascular grafts, including highly angulated infrarenal
aortic necks, were not supported with midterm clinical
data strictly applying the Chaikof criteria. Table V summa-
rizes the IFU for EVAR indications for CE-approved stent
prostheses.
Applying the Anaconda device in severe angulated
necks outside the IFU challenged the participating EVAR
teams in more than one way. In the present study, the
operative procedures were custom-made in nearly every in-
dividual case.
Because of inclined (ie, nonperpendicular to the ﬂow
lumen) placement of the proximal stent rings in the
severely angulated neck, signiﬁcant mean oversizing
(30%) of the body was applied.
In this multicenter study, the participating hospitals
were acknowledged EVAR experts. The patients were
treated in their own regional hospital. They were visited
by the proctors of the coordinating Anaconda study hospi-
tal (Medical Spectrum Twente, Enschede) during the spe-
ciﬁc EVAR procedure in the MANSA study protocol. In
this way, the local EVAR teams could be introduced to
the Anaconda endovascular graft in difﬁcult cases, expand-
ing the indication for treatment. Introducing the
Anaconda in different hospital settings could have implica-
tions for these study results. The four clinical failures in
30 days occurred in four different participating centers,
including the center with the leading number of MANSA
patients. Two of the clinical failures were technical failures
during operation and were reported at the beginning of
the study in each particular hospital and reﬂect the difﬁ-
culties in the use of the Anaconda stent in hostile neck
anatomy.
A weakness of this study is the small inclusion of
patients in most of the participating centers. There was
no true learning curve with the use of the Anaconda in
severely angulated aneurysms, although an experienced
proctor was always available during the procedure.
More than a decade of experiences with the Anaconda
endovascular graft indicated that only in reversed conical
and bell shaped necks it is challenging to obtain proper
sealing and ﬁxation of the Anaconda body. In line with
Chauhuri, we disapprove the use a (standard) endovascular
graft outside the IFU in very short segmented necks(#5 mm).24 Complications such as type I endoleak, neck
dilatation, and endovascular graft migration were seen in
angulated neck studies and represent the challenges of
EVAR in these circumstances.25,26 We anticipate that
such an EVAR procedure must be primarily executed in
high-volume centers. In this study, all participating centers
were experienced in EVAR.
Long-term follow-up is thereby necessary because in
general, reinterventions after the ﬁrst year were still neces-
sary in a signiﬁcant part of this population.7-9
CONCLUSIONS
Summarizing the present experiences, we conclude
that open AAA repair is still a preferable option in patients
with challenging aortic neck anatomy and who are ﬁt for
open surgery.
We thank all participating physicians and hospitals for
including patients in this MANSA study. We are also grate-
ful to Anja Stam, clinical research ofﬁcer, for her help in
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APPENDIX (online only). Full list of Multicenter Angulated Neck Study with the Anaconda endovascular graft
(MANSA) study participants
Hospital Physician Number of patients
Medical Spectrum Twente, Enschede, The Netherlands R.H. Geelkerken, MD, PhD 25
Antonius Hospital Nieuwegein, The Netherlands J.P. de Vries, MD, PhD 2
Leiden University Medical Centre, The Netherlands Prof. J.J. Hamming, MD, PhD 2
Ikazia Hospital, Rotterdam, The Netherlands P.T. den Hoedt, MD, PhD 2
St Jansdal Hospital, Harderwijk, The Netherlands W.L. Akkersdijk, MD, PhD 1
Rijnland Hospital, Leiderdorp, The Netherlands P.P.A. Hedeman Joosten, MD, PhD 1
Gelre Hospital, Apeldoorn, The Netherlands H.C.J.L. Busscher, MD, PhD 1
Erasmus Hospital, Rotterdam, The Netherlands Prof. H.J.M. Verhagen, MD, PhD 1
TerGooi Hospital, Hilversum, The Netherlands E.J.F. Hollander, MD, PhD 1
Total number 36
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